医学
首脑会议
地球仪
全球卫生
脊柱(分子生物学)
专业协会
公共关系
医疗保健
医学教育
护理部
经济增长
政治学
公共卫生
分子生物学
自然地理学
生物
眼科
地理
经济
作者
Sami Aleissa,Koji Tamai,Faisal Konbaz,Ahmed Alturkistany,T. R. Blattert,Harvinder Singh Chhabra,Giuseppe Costanzo,Edward J. Dohring,Frank Kandziora,Ralph Kothe,Bernardo Misaggi,Eric J. Muehlbauer,Paulo Pereira,Shanmuganathan Rajasekaran,William J. Sullivan,Eeric Truumees,Yahya Alqahtani,Hana Alsobayel,Jörg Franke,Marco Teli
标识
DOI:10.1007/s00586-021-06890-5
摘要
Abstract Purpose The Global Burden of Diseases (GBD) Studies have estimated that low back pain is one of the costliest ailments worldwide. Subsequent to GBD publications, leadership of the four largest global spine societies agreed to form SPINE20. This article introduces the concept of SPINE20, the recommendations, and the future of this global advocacy group linked to G20 annual summits. Methods The founders of SPINE20 advocacy group coordinated with G20 Saudi Arabia to conduct the SPINE20 summit in 2020. The summit was intended to promote evidence-based recommendations to use the most reliable information from high-level research. Eight areas of importance to mitigate spine disorders were identified through a voting process of the participating societies. Twelve recommendations were discussed and vetted. Results The areas of immediate concern were “Aging spine,” “Future of spine care,” “Spinal cord injuries,” “Children and adolescent spine,” “Spine-related disability,” “Spine Educational Standards,” “Patient safety,” and “Burden on economy.” Twelve recommendations were created and endorsed by 31/33 spine societies and 2 journals globally during a vetted process through the SPINE20.org website and during the virtual inaugural meeting November 10–11, 2020 held from the G20 platform. Conclusions This is the first time that international spine societies have joined to support actions to mitigate the burden of spine disorders across the globe. SPINE20 seeks to change awareness and treatment of spine pain by supporting local projects that implement value-based practices with healthcare policies that are culturally sensitive based on scientific evidence.
科研通智能强力驱动
Strongly Powered by AbleSci AI